#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Follicular lymphoma stage II Growth hormone deficiency Hyperinsulinaemic hypoglycaemia Lupus nephritis Acute myeloid leukaemia refractory Osteochondrodysplasia Henoch-Schonlein purpura nephritis Amyotrophic lateral sclerosis Cutaneous T-cell lymphoma stage II Hypophosphatasia Acute graft versus host disease in intestine Dementia Alzheimer's type Central nervous system neoplasm Arterial tortuosity syndrome Piriformis syndrome More trials…

    Learn about Rare Diseases

    Ewing’s sarcoma recurrent – Diagnostics Methylmalonic acidaemia – Basic Information Lymphangiosarcoma – Life with Disease Rett syndrome – Treatment Familial haemophagocytic lymphohistiocytosis – Basic Information Hairy cell leukaemia – Trials in Disease Epidermolysis bullosa – Treatment Anaplastic thyroid cancer – Treatment Vascular malformation – Basic Information Angiosarcoma metastatic More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    HYDROGEN Sacubitril Metformin Metoprolol Succinate Op-1250 Hydrocortisone Ph. Eur. SODIUM SELENITE PENTAHYDRATE Loratadine Cobicistat Doxribtimine Keto-Isoleucine Calcium Divarasib Motixafortide Rbl007.2 Amg 193 Cilastatin Sodium Hct116-B Danicopan Argipressin Cemdisiran More therapies…

    Learn about Your Condition

    Obsessive-compulsive disorder Depression Ventricular fibrillation Malformation venous Burkitt's lymphoma Skin bacterial infection Cardiac arrest Pain Post procedural hypotension Vulvovaginal pain Factor IX deficiency Food allergy Binge eating Thrombectomy Hyperkalaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Uniwersyteckie Centrum Medycyny Morskiej I Tropikalnej…

Uniwersyteckie Centrum Medycyny Morskiej I Tropikalnej

Ul. Powstania Styczniowego 9b, Gdynia, 81-519, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Ferric Derisomaltose
    Bulgaria Croatia Czechia Denmark Hungary Latvia +6

  • Study on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation

    Recruiting

    3 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Abelacimab
    Bulgaria Croatia Czechia Estonia Finland Germany +9

  • Study of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity

    Recruiting

    3 1
    Investigated Diseases:
    • Cardiac failure
    • Obesity
    Bulgaria Czechia Denmark France Germany Greece +4

  • Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Arteriosclerosis
    • Obesity
    • Overweight
    Bulgaria Czechia Denmark France Germany Greece +4

  • Study on Empagliflozin and Dapagliflozin for Patients Hospitalized with Acute Heart Failure

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Dapagliflozin
    • Empagliflozin
    Poland

  • Study on the Effects of Sertraline on Anxiety and Depression in Heart Failure Patients with Preserved Ejection Fraction

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Anxiety
    • Depression
    • Heart failure with preserved ejection fraction
    Investigated Drugs:
    • Sertraline
    Poland

  • Study of dapagliflozin effects in patients hospitalized with acute heart failure

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Cardiac failure acute
    Investigated Drugs:
    • Dapagliflozin Propanediol Monohydrate
    Czechia Hungary Poland

  • Study on the Effects of Oxygen Therapy with Vedolizumab, Ustekinumab, or Infliximab for Adults with Moderate to Severe Ulcerative Colitis

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Infliximab
    • Oxygen
    • Ustekinumab
    Poland

  • Study on the Effects of Trimetazidine on Heart Failure with Preserved Ejection Fraction in Patients

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Cardiac failure chronic
    • Heart failure with preserved ejection fraction
    Investigated Drugs:
    • Trimetazidine Dihydrochloride
    Poland

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!